Skip to main content
NCBI home page
Gut logoLink to Gut
. 1992 May;33(5):678–682. doi: 10.1136/gut.33.5.678

Increased pulmonary and intestinal permeability in Crohn's disease.

A Adenis 1, J F Colombel 1, P Lecouffe 1, B Wallaert 1, B Hecquet 1, X Marchandise 1, A Cortot 1
PMCID: PMC1379301  PMID: 1612487

Abstract

We tested the hypothesis that an increased epithelial permeability may affect sites other than the intestine in patients with Crohn's disease by simultaneously evaluating their pulmonary and intestinal permeability. Pulmonary and intestinal permeability were measured by clearance of inhaled technetium-99m diethylene triamine pentacetate (99mTc-DTPA) and by urinary recovery of chromium-51 ethylene diamine tetracetate respectively in 22 patients with Crohn's disease. The half time clearance of 99mTc-DTPA from lung to blood (t1/2LB) was decreased--that is pulmonary permeability increased--in the whole group of patients with Crohn's disease as compared with 13 controls (median 45.5 minutes (8-160) v 85 minutes (34-130) (p less than 0.003)). When analysed separately only patients with active Crohn's disease (n = 15) had a decreased t1/2 lung to blood v controls (42 minutes (8-160) v 85 minutes (34-130) (p less than 0.0025)). Among patients with active Crohn's disease, six were studied again when their disease was quiescent and their t1/2 lung to blood did not differ significantly. The intestinal permeability was increased in the whole group of Crohn's disease patients as compared with 15 controls (5.25% (1.2-24) v 1.7% (0.65-5.75) (p less than 0.0002)). When analysed separately both patients with active and inactive Crohn's disease had increased intestinal permeability v controls (8.1% (1.6-24) and 3.5% (1.2.9.2) v 1.7% (0.65-5.75)) (p less than 0.0001, p = 0.05 respectively). Six patients with active Crohn's disease were studied again when their disease was quiescent and their intestinal permeability decreased significantly p less than 0.04). Pulmonary permeability was increased in patients with Crohn's disease but was not greatly influenced by Crohn's disease activity as opposed to intestinal permeability. The mechanism of this increase is unknown, but may be related in some patients to the presence of an alveolitis.

Full text

PDF
678

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ainsworth M., Eriksen J., Rasmussen J. W., Schaffalitzky de Muckadell O. B. Intestinal permeability of 51Cr-labelled ethylenediaminetetraacetic acid in patients with Crohn's disease and their healthy relatives. Scand J Gastroenterol. 1989 Oct;24(8):993–998. doi: 10.3109/00365528909089246. [DOI] [PubMed] [Google Scholar]
  2. Barnes R. M., Allan S., Taylor-Robinson C. H., Finn R., Johnson P. M. Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease: is IgA antibody a marker for Crohn's disease? Int Arch Allergy Appl Immunol. 1990;92(1):9–15. doi: 10.1159/000235217. [DOI] [PubMed] [Google Scholar]
  3. Bjarnason I., O'Morain C., Levi A. J., Peters T. J. Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology. 1983 Aug;85(2):318–322. [PubMed] [Google Scholar]
  4. Bonniere P., Wallaert B., Cortot A., Marchandise X., Riou Y., Tonnel A. B., Colombel J. F., Voisin C., Paris J. C. Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies. Gut. 1986 Aug;27(8):919–925. doi: 10.1136/gut.27.8.919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bourke S. J., Banham S. W., McKillop J. H., Boyd G. Clearance of 99mTc-DTPA in pigeon fancier's hypersensitivity pneumonitis. Am Rev Respir Dis. 1990 Nov;142(5):1168–1171. doi: 10.1164/ajrccm/142.5.1168. [DOI] [PubMed] [Google Scholar]
  6. Casellas F., Aguadé S., Soriano B., Accarino A., Molero J., Guarner L. Intestinal permeability to 99mTc-diethylenetriaminopentaacetic acid in inflammatory bowel disease. Am J Gastroenterol. 1986 Sep;81(9):767–770. [PubMed] [Google Scholar]
  7. Chopra S. K., Taplin G. V., Tashkin D. P., Elam D. Lung clearance of soluble radioaerosols of different molecular weights in systemic sclerosis. Thorax. 1979 Feb;34(1):63–67. doi: 10.1136/thx.34.1.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Coates G., O'Brodovich H. Extrapulmonary radioactivity in lung permeability measurements. J Nucl Med. 1987 May;28(5):903–906. [PubMed] [Google Scholar]
  9. Harrison N. K., Glanville A. R., Strickland B., Haslam P. L., Corrin B., Addis B. J., Lawrence R., Millar A. B., Black C. M., Turner-Warwick M. Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance. Respir Med. 1989 Sep;83(5):403–414. doi: 10.1016/s0954-6111(89)80072-1. [DOI] [PubMed] [Google Scholar]
  10. Hollander D., Vadheim C. M., Brettholz E., Petersen G. M., Delahunty T., Rotter J. I. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med. 1986 Dec;105(6):883–885. doi: 10.7326/0003-4819-105-6-883. [DOI] [PubMed] [Google Scholar]
  11. Jenkins R. T., Jones D. B., Goodacre R. L., Collins S. M., Coates G., Hunt R. H., Bienenstock J. Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases. Am J Gastroenterol. 1987 Nov;82(11):1159–1164. [PubMed] [Google Scholar]
  12. Jenkins R. T., Ramage J. K., Jones D. B., Collins S. M., Goodacre R. L., Hunt R. H. Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel disease. Clin Invest Med. 1988 Apr;11(2):151–155. [PubMed] [Google Scholar]
  13. Jewell D. P., Patel C. Immunology of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1985;114:119–126. doi: 10.3109/00365528509093772. [DOI] [PubMed] [Google Scholar]
  14. Jones J. G., Minty B. D., Lawler P., Hulands G., Crawley J. C., Veall N. Increased alveolar epithelial permeability in cigarette smokers. Lancet. 1980 Jan 12;1(8159):66–68. doi: 10.1016/s0140-6736(80)90493-6. [DOI] [PubMed] [Google Scholar]
  15. Jones J. G., Minty B. D., Royston D. The physiology of leaky lungs. Br J Anaesth. 1982 Jul;54(7):705–721. doi: 10.1093/bja/54.7.705-a. [DOI] [PubMed] [Google Scholar]
  16. Katz K. D., Hollander D., Vadheim C. M., McElree C., Delahunty T., Dadufalza V. D., Krugliak P., Rotter J. I. Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology. 1989 Oct;97(4):927–931. doi: 10.1016/0016-5085(89)91499-6. [DOI] [PubMed] [Google Scholar]
  17. Keogh B. A., Hunninghake G. W., Line B. R., Crystal R. G. The alveolitis of pulmonary sarcoidosis. Evaluation of natural history and alveolitis-dependent changes in lung function. Am Rev Respir Dis. 1983 Aug;128(2):256–265. doi: 10.1164/arrd.1983.128.2.256. [DOI] [PubMed] [Google Scholar]
  18. Kirsner J. B., Shorter R. G. Recent developments in "nonspecific" inflammatory bowel disease (first of two parts). N Engl J Med. 1982 Apr 1;306(13):775–785. doi: 10.1056/NEJM198204013061304. [DOI] [PubMed] [Google Scholar]
  19. Kirsner J. B., Shorter R. G. Recent developments in nonspecific inflammatory bowel disease (second of two parts). N Engl J Med. 1982 Apr 8;306(14):837–848. doi: 10.1056/NEJM198204083061404. [DOI] [PubMed] [Google Scholar]
  20. Lemann M., Messing B., D'Agay F., Modigliani R. Crohn's disease with respiratory tract involvement. Gut. 1987 Dec;28(12):1669–1672. doi: 10.1136/gut.28.12.1669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Main J., McKenzie H., Yeaman G. R., Kerr M. A., Robson D., Pennington C. R., Parratt D. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ. 1988 Oct 29;297(6656):1105–1106. doi: 10.1136/bmj.297.6656.1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Meignan M., Rosso J., Robert R. Lung epithelial permeability to aerosolized solutes: relation to position. J Appl Physiol (1985) 1987 Mar;62(3):902–911. doi: 10.1152/jappl.1987.62.3.902. [DOI] [PubMed] [Google Scholar]
  23. Nolop K. B., Maxwell D. L., Fleming J. S., Braude S., Hughes J. M., Royston D. A comparison of 99mTc-DTPA and 113mIn-DTPA aerosol clearances in humans. Effects of smoking, hyperinflation, and in vitro oxidation. Am Rev Respir Dis. 1987 Nov;136(5):1112–1116. doi: 10.1164/ajrccm/136.5.1112. [DOI] [PubMed] [Google Scholar]
  24. O'Brodovich H., Coates G. Pulmonary clearance of 99mTc-DTPA: a noninvasive assessment of epithelial integrity. Lung. 1987;165(1):1–16. doi: 10.1007/BF02714416. [DOI] [PubMed] [Google Scholar]
  25. O'Morain C. A., Abelow A. C., Chervu L. R., Fleischner G. M., Das K. M. Chromium 51-ethylenediaminetetraacetate test: a useful test in the assessment of inflammatory bowel disease. J Lab Clin Med. 1986 Nov;108(5):430–435. [PubMed] [Google Scholar]
  26. Olaison G., Leandersson P., Sjödahl R., Tagesson C. Intestinal permeability to polyethyleneglycol 600 in Crohn's disease. Peroperative determination in a defined segment of the small intestine. Gut. 1988 Feb;29(2):196–199. doi: 10.1136/gut.29.2.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pironi L., Miglioli M., Ruggeri E., Levorato M., Dallasta M. A., Corbelli C., Nibali M. G., Barbara L. Relationship between intestinal permeability to [51Cr]EDTA and inflammatory activity in asymptomatic patients with Crohn's disease. Dig Dis Sci. 1990 May;35(5):582–588. doi: 10.1007/BF01540405. [DOI] [PubMed] [Google Scholar]
  28. Resnick R. H., Royal H., Marshall W., Barron R., Werth T. Intestinal permeability in gastrointestinal disorders. Use of oral [99mTc]DTPA. Dig Dis Sci. 1990 Feb;35(2):205–211. doi: 10.1007/BF01536764. [DOI] [PubMed] [Google Scholar]
  29. Rinderknecht J., Shapiro L., Krauthammer M., Taplin G., Wasserman K., Uszler J. M., Effros R. M. Accelerated clearance of small solutes from the lungs in interstitial lung disease. Am Rev Respir Dis. 1980 Jan;121(1):105–117. doi: 10.1164/arrd.1980.121.1.105. [DOI] [PubMed] [Google Scholar]
  30. Robertson D. A., Taylor N., Sidhu H., Britten A., Smith C. L., Holdstock G. Pulmonary permeability in coeliac disease and inflammatory bowel disease. Digestion. 1989;42(2):98–103. doi: 10.1159/000199832. [DOI] [PubMed] [Google Scholar]
  31. Sanderson I. R., Boulton P., Menzies I., Walker-Smith J. A. Improvement of abnormal lactulose/rhamnose permeability in active Crohn's disease of the small bowel by an elemental diet. Gut. 1987 Sep;28(9):1073–1076. doi: 10.1136/gut.28.9.1073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Shorter R. G., Huizenga K. A., Spencer R. J. A working hypothesis for the etiology and pathogenesis of nonspecific inflammatory bowel disease. Am J Dig Dis. 1972 Nov;17(11):1024–1032. doi: 10.1007/BF02239143. [DOI] [PubMed] [Google Scholar]
  33. Smiéjan J. M., Cosnes J., Chollet-Martin S., Soler P., Basset F. M., Le Quintrec Y., Hance A. J. Sarcoid-like lymphocytosis of the lower respiratory tract in patients with active Crohn's disease. Ann Intern Med. 1986 Jan;104(1):17–21. doi: 10.7326/0003-4819-104-1-17. [DOI] [PubMed] [Google Scholar]
  34. Ukabam S. O., Clamp J. R., Cooper B. T. Abnormal small intestinal permeability to sugars in patients with Crohn's disease of the terminal ileum and colon. Digestion. 1983;27(2):70–74. doi: 10.1159/000198932. [DOI] [PubMed] [Google Scholar]
  35. Wallaert B., Aerts C., Bart F., Hatron P. Y., Dracon M., Tonnel A. B., Voisin C. Alveolar macrophage dysfunction in systemic lupus erythematosus. Am Rev Respir Dis. 1987 Aug;136(2):293–297. doi: 10.1164/ajrccm/136.2.293. [DOI] [PubMed] [Google Scholar]
  36. Wallaert B., Aerts C., Bonniere P., Cortot A., Tonnel A. B., Paris J. C., Voisin C. Superoxide anion generation by alveolar macrophages in Crohn's disease. N Engl J Med. 1985 Feb 14;312(7):444–445. doi: 10.1056/NEJM198502143120715. [DOI] [PubMed] [Google Scholar]
  37. Wallaert B., Colombel J. F., Tonnel A. B., Bonniere P., Cortot A., Paris J. C., Voisin C. Evidence of lymphocyte alveolitis in Crohn's disease. Chest. 1985 Mar;87(3):363–367. doi: 10.1378/chest.87.3.363. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES